Sign inJoin waitlistJoin the waitlist

James Lah

Vice Chair, Neurology, Emory University · Emory University School of Medicine

Credentials: · · · ·

History

Neurology · Emory University School of Medicine
Present
Emory University School of Medicine
Present
Emory University School of Medicine
Present

Internal Medicine
Emory University School of Medicine
1992–1993
Neurology
Emory University School of Medicine
1990–1993
Ohio State University College of Medicine
1988–1992
Duke University
1984–1988

Research

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Systematic review or meta-analysis · Nature Genetics · 2019 · 2,420 citations
Variant of TREM2 associated with the risk of Alzheimer's disease
New England Journal of Medicine · 2013 · 2,080 citations
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Systematic review or meta-analysis · Nature Genetics · 2011 · 1,577 citations

Allan Levey
228 papers
Thomas Wingo
55 papers
AW
Aliza Wingo
35 papers
EJ
Erik Johnson
32 papers
Chadwick Hales
26 papers
David Bennett
24 papers
Juan Troncoso
20 papers
Philip De Jager
20 papers
TB
Thomas Beach
20 papers
Eric Reiman
17 papers
Dennis Dickson
16 papers
John Trojanowski
16 papers

Grants

Goizueta Alzheimer's Disease Research Center
National Institute on Aging · P30
Project lead · $3.3M · Emory University
2020–2030
Translation of GluN2B-Selective PET Radiopharmaceuticals in Alzheimers Patients
National Institute on Aging · R01
PI · $2.3M · Emory University
2023–2029
Explainable and Ethical AI for Studying Alzheimer's Disease
National Institute on Aging · R01
PI · $2.1M · Emory University
2024–2029
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
National Institute on Aging · R01
Contact PI · $35.2M · Emory University
2021–2027

Clinical trials

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Principal investigator · Enrolling by invitation
Emory University
2025–2028
Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials
Principal investigator · Completed
Emory University
2018–2020
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034